BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cole BA, Johnson RM, Dejakaisaya H, Pilati N, Fishwick CWG, Muench SP, Lippiat JD. Structure-Based Identification and Characterization of Inhibitors of the Epilepsy-Associated KNa1.1 (KCNT1) Potassium Channel. iScience 2020;23:101100. [PMID: 32408169 DOI: 10.1016/j.isci.2020.101100] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Olivet J, Maseko SB, Volkov AN, Salehi-Ashtiani K, Das K, Calderwood MA, Twizere JC, Gorgulla C. A systematic approach to identify host targets and rapidly deliver broad-spectrum antivirals. Mol Ther 2022;30:1797-800. [PMID: 35231394 DOI: 10.1016/j.ymthe.2022.02.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 M Qunies A, A Emmitte K. Small-molecule inhibitors of Slack potassium channels as potential therapeutics for childhood epilepsies. Pharm Pat Anal 2022. [PMID: 35369761 DOI: 10.4155/ppa-2022-0002] [Reference Citation Analysis]
3 Zhang Q, Liu Y, Xu J, Teng Y, Zhang Z. The Functional Properties, Physiological Roles, Channelopathy and Pharmacological Characteristics of the Slack (KCNT1) Channel. Adv Exp Med Biol 2021;1349:387-400. [PMID: 35138624 DOI: 10.1007/978-981-16-4254-8_18] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cole BA, Clapcote SJ, Muench SP, Lippiat JD. Targeting KNa1.1 channels in KCNT1-associated epilepsy. Trends Pharmacol Sci 2021;42:700-13. [PMID: 34074526 DOI: 10.1016/j.tips.2021.05.003] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Griffin AM, Kahlig KM, Hatch RJ, Hughes ZA, Chapman ML, Antonio B, Marron BE, Wittmann M, Martinez-Botella G. Discovery of the First Orally Available, Selective KNa1.1 Inhibitor: In Vitro and In Vivo Activity of an Oxadiazole Series. ACS Med Chem Lett 2021;12:593-602. [PMID: 33859800 DOI: 10.1021/acsmedchemlett.0c00675] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
6 Becchetti A, Grandi LC, Colombo G, Meneghini S, Amadeo A. Nicotinic Receptors in Sleep-Related Hypermotor Epilepsy: Pathophysiology and Pharmacology. Brain Sci 2020;10:E907. [PMID: 33255633 DOI: 10.3390/brainsci10120907] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
7 Spitznagel BD, Mishra NM, Qunies AM, Prael FJ 3rd, Du Y, Kozek KA, Lazarenko RM, Denton JS, Emmitte KA, Weaver CD. VU0606170, a Selective Slack Channels Inhibitor, Decreases Calcium Oscillations in Cultured Cortical Neurons. ACS Chem Neurosci 2020;11:3658-71. [PMID: 33143429 DOI: 10.1021/acschemneuro.0c00583] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]